Business & Finance
Adams Respiratory Therapeutics reports 26% increase in income
Published in Healthcare Finance, Tax and Law Weekly, December 6th, 2006
Commenting on the company's fiscal 2007 first quarter results, Michael J. Valentino, president and CEO, said, "With net sales of $90.1 million, we achieved solid year-over-year increases in pre-tax income and income per diluted share of 26% and 22%, respectively. These results are very impressive, especially given the fact that our pre-tax income of $25.4 was inclusive of a one-time pre-tax charge of $9.7 million - or $0.17 in diluted earnings per share - related to the July 31, 2006, repurchase of the Fort Worth manufacturing assets."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Behavior
Scientists at City University of New York, Department of Psychology target behavior - Business & Finance
Acadia Pharmaceuticals posts loss of $11.3 million - Business & Finance
Advanced Life Sciences records net loss of $0.24 per share - Business & Finance
Amicas reports quarterly positive operating cash flow - Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share - Business & Finance
Bentley Pharmaceuticals experiences 7% revenue growth - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
